|
|
||||||||
1 Department of Physiology, University of North Dakota School of Medicine, Grand Forks, North Dakota 58202; and 2 Department of Physiology, Tulane University School of Medicine, New Orleans, Louisiana 70112
| |
ABSTRACT |
|---|
|
|
|---|
The present study was performed to determine whether renal efferent sympathetic neurons could be identified using a retrograde neuronal tracer without compromising renal function and whether the labeling and identification procedure alters Ca2+ currents and neuromodulation of those neurons. Renal sympathetic and superior cervical ganglion (SCG) neurons were labeled with the fluorescent retrograde tracer fast blue. Renal function studies made 1 wk after labeling revealed that renal hemodynamics and fluid and electrolyte excretion were similar between the dye-injected (left) kidney and the control (right) kidney under control conditions and after hemorrhage. After volume expansion, urine flow in the dye-injected kidney was slightly, but significantly, less than that of the control kidney, whereas urinary sodium excretion increased by approximately ninefold in both kidneys. Patch-clamp studies of SCG neurons in 10 mM external Ca2+ revealed that peak currents were not affected by the presence of the dye or a 1-min exposure to ultraviolet (UV) light. Neither maximal norepinephrine-induced Ca2+ current inhibition nor the sensitivity to norepinephrine was affected by the dye or 1-min UV exposure. Facilitation protocols revealed that G protein modulation of Ca2+ currents remained intact in dye-labeled UV-exposed neurons. This study demonstrates that a retrograde fluorescent dye technique to identify renal sympathetic neurons does not compromise renal function and the presence of the dye label or UV exposure has no effect on Ca2+ currents and neuromodulation in these neurons. Isolation of single identified renal sympathetic neurons coupled with patch-clamp techniques represents a tool to investigate the role of individual current systems in the modulation of excitability in these neurons, which play an important role in the control of renal hemodynamics and excretory function and in the pathogenesis of hypertension.
retrograde labeling technique; fast blue microinjections; renal projection neurons; calcium current; patch clamp
| |
INTRODUCTION |
|---|
|
|
|---|
NORMALLY FUNCTIONING kidneys exhibit the phenomenon of pressure natriuresis, which allows the kidneys to respond to elevations in arterial pressure by increasing sodium and water excretion. During periods of elevated blood pressure this mechanism increases urine output and eliminates extraneous volume until the arterial pressure is normalized. If arterial pressure falls, urine output is reduced until the arterial pressure is again normalized (12). A number of observations suggest that the renal efferent sympathetic nerves play a pivotal role in long-term blood pressure regulation by modulating renal hemodynamic and excretory function and consequently the pressure-natriuresis relationship. This modulation by the renal nerves occurs primarily via increased renal vascular resistance, increased renal sodium and water reabsorption, and increased renin release (5, 6). Results from measurements of renal tissue norepinephrine concentration or renal vein norepinephrine spillover, renal nerve stimulation and recording experiments, as well as renal denervation studies in various hypertensive models all suggest that altered renal sympathetic nerve activity contributes to the derangements in renal function that lead to the development of hypertension (5, 14, 24).
Despite the wealth of evidence implicating the renal nerves in the development of hypertension, few, if any, studies of the electrophysiological behavior of efferent sympathetic neurons have been performed. This is mainly due to technical difficulties associated with isolation of renal sympathetic neurons because the nerve cell bodies are located in the paravertebral ganglia and celiac ganglion complex and make up only a small proportion of the neurons of these ganglia (23, 27). The advent of fluorescent retrograde tracers has enabled isolation and identification of single neuron cell bodies for the investigation of the biophysical properties of these neurons using the patch-clamp technique (15). Two potential problems exist that could seriously compromise electrophysiological studies of identified renal sympathetic neurons. First, the dye-labeling technique employs application of the fluorescent tracer to the nerve terminals by microinjection into the kidney and could adversely affect renal hemodynamic and excretory function, thereby compromising the regulation of extracellular fluid volume and mean arterial pressure in the animals studied. Second, the dye or UV illumination required to identify the labeled neurons could alter their properties, compromising the subsequent electrophysiological studies.
The present study was performed to determine whether renal efferent sympathetic neurons of normotensive rats can be identified and isolated by injecting the retrograde tracer fast blue directly into the kidney and whether this dye-label injection procedure adversely affects renal hemodynamic and excretory function. In addition, we determined whether the presence of the tracer and the short period of UV illumination required to identify dispersed renal sympathetic neurons altered G protein modulation of Ca2+ currents in these neurons.
| |
METHODS |
|---|
|
|
|---|
Animals. Male Sprague-Dawley rats (Harlan, Indianapolis, IN) weighing between 300 and 400 g were used in the present study. The rats were maintained on a 12:12-h light-dark cycle and were fed standard laboratory rat chow (Purina, Richmond, IN) and had free access to water.
Identification of renal sympathetic neurons. Renal efferent sympathetic neurons were labeled using the fluorescent retrograde tracer fast blue, after aseptic surgical isolation of the left kidney (23, 27). Briefly, the rats were anesthetized with pentobarbital sodium (50 mg/kg ip), and the left kidney was exteriorized via a flank incision. A total of 10 µl of 2% fast blue in distilled water was injected at multiple sites (~10) into the kidney cortex via a 30-gauge needle connected to a solenoid-controlled pressure-injection system. After injection of the fluorescent tracer the abdominal musculature was sutured and the skin was closed with wound clips. The animals received an injection of penicillin-streptomycin to prevent infection and were placed on a heating pad to recover from the effects of the anesthesia. Renal function studies were performed 1 wk later according to the following protocol.
Renal function studies.
Ten rats previously injected with the retrograde tracer were prepared
for renal function experiments in the following manner. The animals
were anesthetized with Inactin (100 mg/kg ip) and placed on a
thermostatically controlled heated surgical table. After a
tracheostomy, a polyethylene catheter (PE-50) was inserted into a
carotid artery for measurement of mean arterial pressure (MAP) and
collection of arterial blood samples. Both jugular veins were
catheterized to allow continuous infusion of solutions and additional
anesthetic as required. The animals received an intravenous bolus
injection of an isotonic saline solution containing 10% inulin and
1.28% p-aminohippurate (PAH),
administered at 200 µl/100 g body wt. This injection was followed by
a continuous infusion of isotonic saline containing 5% inulin and
0.64% PAH at a rate of 500 µl · 100 g body
wt
1 · h
1.
After a laparotomy, the left and right ureters were catheterized (PE-10) to obtain free-flow urine collections from the left (dye injected) and right (control) kidneys. A surgical stabilization period
of at least 30 min was observed, and then coincident with at least 60 min of inulin-PAH infusion the first of two consecutive 30-min baseline
renal clearance periods was begun. A 200-µl arterial blood sample was
obtained at the beginning, midpoint, and end of the 60-min control
(Pre) period. These two baseline renal clearance periods (Pre) were
obtained in all 10 rats. The rats were then randomly divided into two
groups. Group 1 consisted of five rats that were subjected to a rapid hemorrhage maneuver totaling 5% of
calculated blood volume (~8% of body wt). After a 30-min
equilibration period a third clearance period (Post) of 30 min was then
obtained. The five rats in group 2 were infused intravenously with 0.9% saline to achieve a volume
expansion of 2.5% body wt in 30 min. The saline infusion was then
matched to urinary output, and a 30-min (Post) clearance period was
then obtained in these rats. In both groups, arterial blood samples
(200 µl) were obtained at the beginning, midpoint, and end of the
experimental (Post) clearance period. After completion of the
experimental (Post) period in both groups, the animals were prepared
for cell isolation as subsequently described. Coincident with the cell
isolation procedure the kidneys were inspected for visible damage,
removed from the animal, blotted dry, and weighed.
Isolation of renal sympathetic neurons. After the renal function protocol, the rats were decapitated while they were still anesthetized, and paravertebral ganglion (PVG) neurons were isolated using the enzymatic dispersion technique described previously (22). Briefly, the peritoneal cavity was opened, the viscera were removed, and the peritoneal cavity was irrigated with ice-cold Hanks' balanced salt solution (HBSS). The left paravertebral ganglia (T12-L1) were dissected free, and the connective tissue capsule was removed. The ganglia were then minced and transferred to 5 ml of modified Earle's balanced salt solution (EBSS) containing 1 mg/ml collagenase D and 0.5 mg/ml trypsin (Boehringer Mannheim Biochemicals, Indianapolis, IN) and 0.1 mg/ml DNase type I (Sigma, St. Louis, MO). The EBSS was modified by the addition of 3.6 g/l glucose and 10 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES) and adjusted to pH 7.4 with NaOH before the addition of NaHCO3. The enzyme solution containing the ganglion fragments was then incubated at 34°C under 5% CO2-95% O2 in a shaking water bath. After 1 h, the flask was shaken vigorously by hand to release the cell somata from the ganglion fragments. The resulting cell suspension was brought up to 10 ml by the addition of modified HBSS containing 10% fetal calf serum (GIBCO, Grand Island, NY), 10 mM CaCl2, and 5 mM HEPES and then centrifuged at 50 g for 5 min. Finally, the resulting pellet was gently resuspended in the above solution and aliquoted into 35-mm poly-L-lysine-coated tissue culture dishes (1 ganglion/dish).
After isolation, the somata of single neurons were visualized using phase-contrast and epifluorescence optics attached to a Nikon-Diaphot inverted microscope. The fast blue-labeled renal efferent sympathetic neurons were identified by their fluorescence using broad-band UV excitation (330-380 nm).Isolation and patch clamp of dye-labeled sympathetic neurons. In order to obtain a large yield of fast blue-labeled sympathetic neurons for the patch-clamp studies, superior cervical ganglion (SCG) neurons from adult male Wistar rats (250-450 g) were labeled by a single intraperitoneal injection of fast blue (0.2 ml of 0.1% wt/vol, in normal saline) (Sigma Chemical) at least 1 wk before recording.
SCG neurons of both the injected and uninjected control rats were acutely isolated using the enzymatic dispersion technique described above. The fast blue retrograde-labeled neuronal somata were visualized as described, identified as described above, and repositioned in the center of the recording chamber for electrophysiological recording. Once in position, which required ~5 s, the excitation shutter was closed, and patch-clamp recording conditions were established.Whole cell voltage clamp.
Isolated single (fast blue labeled or unlabeled) neurons were studied
with the whole cell variant of the patch-clamp technique (13) using an
Axoclamp 1-C patch-clamp amplifier (Axon Instruments). Patch electrodes
were fabricated from N51A borosilicate capillary tubing (Garner Glass)
using a model P 80/PC flaming brown micropipette puller (Shutter
Instrument). Before use, pipettes were coated with Sylgard (Dow
Corning) and fire-polished on a microforge (Narashige Scientific
Instrument Laboratory) and had resistances of 1-2 M
when filled
with internal solution.
3 dB) using a
four-pole low-pass bessel filter, digitized with a 12-bit
analog-to-digital converter (GW Instruments), and stored for analysis
using a Macintosh II microcomputer (Apple Computer). Voltage paradigms
were generated from a 12-bit digital-to-analog converter (GW
instruments) using S3, data acquisition software designed by Dr. S. R. Ikeda (Guthrie Research Institute, Sayre, PA).
Ca2+ currents were isolated from
other potentially contaminating currents by ion substitution and
pharmacological agents. Potassium currents were eliminated by including
tetraethylammonium chloride (TEA-Cl) in both the internal (pipette) and
external solutions and employing
N-methyl-D-glucamine
(NMG) as the major internal cation. Sodium currents were eliminated by
adding 0.1 µM tetrodotoxin (TTX) in the external solution in addition
to substituting external NaCl with TEA-Cl. The internal solution
contained (in mM) 120.0 NMG, 10.0 TEA-Cl, 10.0 HEPES, 11.0 EGTA, 1.0 CaCl2, 40.0 sucrose, 4.0 MgATP,
and 1.0 Na2GTP. The external
solution contained (in mM) 140.0 TEA-Cl, 10.0 HEPES, 45.0 sucrose, 10.0 glucose, 10.0 CaCl2, 0.8 MgCl2, and 0.0001 TTX. Both the
internal and external solutions were adjusted to a pH of 7.4 with HCl
and TEAOH and had osmolalities of approximately 280 and 300 mosmol/kgH2O, respectively. All
the experiments were performed at room temperature (22-24°C).
Data analysis.
Renal function data were analyzed with a two-way analysis of variance
with repeated measures on one factor, and
Ca2+ current data were analyzed
with a one-way analysis of variance. The least significant difference
test was applied post hoc to locate significant differences within and
between appropriate groups at the P
0.05 level. Data are reported as means ± SE.
| |
RESULTS |
|---|
|
|
|---|
Phase-contrast and fluorescence photomicrographs of an intact ganglion
and a field of acutely isolated neurons are presented in Fig.
1. The fluorescence photomicrograph of a
whole mount of the paravertebral ganglion
T12 isolated 1 wk after the
injection of 10 µl of fast blue into the ipsilateral kidney (Fig.
1B) shows intensely fluorescent
cells scattered throughout the ganglion. Figure
1C shows a phase-contrast
photomicrograph of a field of acutely isolated neurons. The arrows
indicate fluorescent efferent sympathetic neurons, which can be
identified by epifluorescence optics in Fig.
1D.
|
The baseline MAP and heart rates in the hemorrhage group averaged 126 ± 4 mmHg and 369 ± 13 beats/min, respectively, values not different from those in the volume expansion group (124 ± 3 mmHg and 365 ± 12 beats/min). Similarly, there were no differences between the body weights (375 ± 15 vs. 388 ± 10 g), left kidney weights (1.34 ± 0.09 vs. 1.31 ± 0.09 g), or right kidney weights (1.33 ± 0.10 vs. 1.40 ± 0.10 g) of the hemorrhage and volume expansion groups, respectively. Hematocrit and plasma protein concentration were also similar in the two groups and averaged 50.0 ± 0.7% and 5.0 ± 0.0 g/dl in the hemorrhage group and 50.0 ± 0.9% and 4.8 ± 0.2 g/dl, respectively, in the volume expansion group.
Renal function measurements obtained from the rats before and after
either 5% blood volume hemorrhage or 2.5% body weight volume
expansion are presented in Table 1.
Baseline renal function was not significantly different between the
dye-injected (left) kidney and the control (right) kidney within either
group. Indeed, there were no differences between the GFR, estimated
renal plasma flow (CPAH), urine
flow, or urinary sodium excretion of the injected and noninjected
kidneys in either group (Table 1). GFR ranged from 0.90 to 1.12 ml · min
1 · g
1
and CPAH ranged from 3.68 to 3.91 ml · min
1 · g
1.
These measured baseline renal excretory and hemodynamic variables are
within the normal range for rats under similar experimental conditions
(1, 25).
|
After 5% blood volume hemorrhage, MAP decreased from 126 ± 4 to 103 ± 5 mmHg (P < 0.05). This decrease was accompanied by slight reductions in renal hemodynamics and renal excretory function (Table 1) in both the dye-injected (left) and control kidneys (right); however, these changes did not reach statistical significance. MAP was unchanged after 2.5% body wt saline volume expansion (124 ± 3 vs. 121 ± 6 mmHg, NS). Similarly, both GFR and CPAH were slightly elevated after volume expansion in the injected and control kidneys, but these changes did not reach statistical significance. However, volume expansion elicited marked increases in renal excretory function. Urine flow increased from 3.7 ± 0.9 to 13.0 ± 1.7 µl/min (P < 0.05) in the dye-injected kidney and from 4.8 ± 1.0 to 19.1 ± 2.7 µl/min (P < 0.05) in the contralateral control kidney. The magnitude of the volume expansion-induced increase in urine flow in the dye-injected kidney (9.3 ± 1.2 µl/min) was slightly but significantly smaller (P < 0.05) than in the contralateral control kidney (14.3 ± 2.0 µl/min). Urinary sodium excretion increased in both kidneys approximately ninefold from 0.33 ± 0.21 to 3.01 ± 0.51 µeq/min in the dye-injected kidney and from 0.43 ± 0.20 to 4.26 ± 0.82 µeq/min in control kidneys. Urinary potassium excretion tended to be elevated in both kidneys after volume expansion, but these changes did not reach statistical significance.
Ca2+ current
modulation of labeled and unlabeled sympathetic neurons.
For patch-clamp studies of Ca2+
currents, four groups of neurons were used. SCG neurons isolated from
uninjected control rats were prepared for patch-clamp recording and
either received no UV illumination (group 1)
or were illuminated with UV for 1 min (group
2). SCG neurons isolated from rats that were labeled
by a single intraperitoneal injection of fast blue 1 wk before the experiment were illuminated by UV for only 5 s, enough to position an
identified neuron for recording, and then either received no further UV
(group 3) or were illuminated for a further 1 min (group 4). Cell capacitance and series
resistances estimated from the transient cell charging currents were
not different between the four groups of neurons as follows:
group 1 42.8 ± 2.0 pF, 3.1 ± 0.1 M
, n = 41;
group 2 44.0 ± 2.6 pF, 3.1 ± 0.1 M
, n = 26; group 3 45.8 ± 3.5 pF, 3.4 ± 0.3 M
, n = 18; and
group 4 42.1 ± 1.9 pF, 3.1 ± 0.2 M
, n = 28.
80 mV to the indicated potentials
are shown before (Fig. 2A,
left) and after 1 min of UV exposure
(Fig. 2A,
right). The mean current-voltage
relationships for the labeled neurons, before and after UV exposure,
are shown in Fig. 2B. In both groups,
current amplitude, measured as the average current occurring
7.0-7.5 ms after the onset of the voltage step, increased as step
potential increased to near +10 mV. At step potentials more positive
than +10 mV, Ca2+ current
amplitude declined toward a zero current asymptote at potentials near
+80 mV. Figure 2C shows no difference
in mean current amplitudes between the four groups of neurons before or after UV exposure when measured at +10 mV, the peak of the
current-voltage curve.
|
80 mV at 0.1 Hz. After adequate dialysis with the internal
solution, as judged by the disappearance of outward current components
and stabilization of the Ca2+
current amplitude, the cell was exposed to UV for 1 min by reopening the excitation shutter or was left unexposed for 1 min as a time control. After the 1-min exposure period, the cell was superfused with
control external solution by a gravity-fed multibarrel superfusion device. After establishing a baseline, norepinephrine at various concentrations was superfused onto the cell. The larger concentrations of norepinephrine produced an initial rapid decrease in the
Ca2+ current amplitude,
occasionally followed by a small relief of block or desensitization
during the continued presence of norepinephrine. After 1 min the cell
was washed by changing the superfusion to normal external solution and
the current amplitude returned toward control levels.
Ca2+ current inhibition was
measured as the maximum inhibition that occurred during a 1-min
exposure compared with the average of the pre- and post-norepinephrine
current amplitudes. This application method allowed for several
norepinephrine applications to a single cell. To reduce any effects of
desensitization norepinephrine concentrations were superfused onto the
cells in random order. Figure 3, B and
C, shows that the apparent
Kd for
norepinephrine and maximal norepinephrine-induced inhibition of the
Ca2+ current were not different
between the four groups of neurons.
|
80 mV and then stepped to +10 mV to measure the inhibited
current. The membrane is then stepped to +80 mV to facilitate the
Ca2+ current, stepped back to
80 mV, and then stepped to the test potential of +10 mV. The
ratio of current amplitude with and without the depolarizing prepulse
is a measure of facilitation. As the interval between the facilitating
pulse and the test pulse is increased with subsequent sweeps, the
facilitation of the current is lost as inhibition is reestablished. The
time course of recovery of inhibition presumably represents rebinding
of the activated G protein subunit to the
Ca2+ channel, a first-order
process dependent on G protein concentration (7, 10). Figure
4B shows that there was no difference
in the magnitude of Ca2+ current
facilitation induced by a prepulse in the presence of 10 µM
norepinephrine for the four groups of neurons. Moreover, the time
constant of reinhibition for the four groups of neurons in Fig.
4C was also not different, indicating
that neither the dye label nor 1 min of UV exposure compromises G
protein-mediated Ca2+ current
inhibition. The SCG neurons used in this study provided strong evidence
that the fluorescent tracer and UV illumination used to identify
target-specific neurons had no deleterious effect on the properties of
Ca2+ currents of those neurons. It
is possible, however, that renal efferent sympathetic neurons may react
differently to the tracer or UV illumination. We therefore investigated
Ca2+ current density,
norepinephrine-induced inhibition of the
Ca2+ current, and
Ca2+ current facilitation after
norepinephrine-induced inhibition in PVG neurons labeled by the
dye-injection procedure described for the renal function studies.
Ca2+ current density of unlabeled
PVG neurons was 48.53 ± 3.19 pA/pF (n = 18), a value not different from
the current density of the labeled neurons, 55.05 ± 4.91 pA/pF
(n = 9). The inhibition elicited by a
nearly maximal concentration of norepinephrine (10 µM) was 43.9 ± 2.6% (n = 14) in unlabeled neurons,
also not different from that obtained from labeled neurons, 52.60 ± 3.4% (n = 7). The
depolarization-induced facilitation after norepinephrine application was also not different between labeled and unlabeled PVG neurons: 200.7 ± 20.4% (n = 5) in unlabeled PVG
neurons compared with 216.4 ± 32.6%
(n = 5) in labeled PVG neurons. The
labeled PVG neurons also displayed no obvious difference in
fluorescence intensity compared with the labeled SCG neurons,
suggesting that they do not exclude or concentrate the dye label
compared with SCG neurons. Thus these data indicate that the
fluorescent tracer or short period of UV illumination required to
identify labeled sympathetic neurons have no deleterious effect on the
function of renal efferent sympathetic neurons.
|
| |
DISCUSSION |
|---|
|
|
|---|
Although retrograde tracer studies have previously been used to identify cells of origin of the sympathetic renal innervation (23, 27), the electrophysiological properties of these cell bodies have yet to be characterized. To evaluate the role of putative electrophysiological derangements in renal efferent cell bodies during the development of hypertension, it is critical that the identification process does not alter renal function, which may in turn alter the temporal pattern and/or severity of the hypertension (5, 14) or the function of the innervating neurons that would be expected to interrupt sympathetic control of the kidney. There are several agents available that can be used to label neurons. In pilot studies we compared blue and green microspheres, fluorogold, and fast blue for their ability to label PVG neurons. In these experiments, only fast blue produced intense labeling of PVG neurons. Rhodamine proved to be the agent of choice over fluorogold, microspheres, and 3,3-diethyloxadicarbocyanine iodide for the identification of cardiac motoneurons (17). It is possible that rhodamine may be less damaging to neurons than fast blue in that UV is not required to excite the dye. However, the biophysical properties of labeled and nonlabeled neurons were not compared in that study (17). We therefore chose to use fast blue in this study because it has previously been shown to be highly effective for the identification of renal efferent sympathetic neurons (24).
The preferred method of labeling large numbers of renal sympathetic neurons is to cut the renal nerves close to their point of entry into the kidney and soak the cut ends in the tracer (27). This procedure is obviated in studies of neuronal function because the axotomy would induce profound alterations of electrophysiological behavior (18-20). An alternative labeling method that preserves axon integrity was used in this study. This method, however, employs multiple injections into the renal cortex to allow uptake of the dye by the sympathetic nerve terminals and transport to the cell bodies in the paravertebral ganglia (23). It is possible that these multiple microinjections into the kidney cortex could cause renal derangements, which might compromise physiological studies. However, the lack of visible damage of dye-injected kidneys suggests that this labeling procedure does not produce profound renal damage. More importantly, the similarity of baseline renal hemodynamics and excretory function in the dye-injected and control kidneys, which are within the normal range for anesthetized rats, provides further direct evidence that renal function is not compromised by the dye-labeling procedure.
A second possible technical complication of this procedure could involve dye-induced damage to the renal nerves. In an effort to address this issue, we evaluated the renal function responses to 5% blood volume hemorrhage. This maneuver has been shown to result in substantial changes in renal hemodynamics and excretory function, which are mediated in large part by activation of renal efferent sympathetic fibers (5). In the present study renal hemodynamics and excretory function of the dye-injected and contralateral control kidneys after 5% blood volume hemorrhage displayed a similar trend to decreased values, which argues against substantial renal nerve damage at the time the renal function experiments were undertaken (1 wk after dye injection). However, the hemorrhage-induced changes did not reach statistical significance in either control or dye-injected kidneys, and therefore altered neuronal function cannot be ruled out by these experiments. Although it is not clear why hemorrhage failed to elicit marked reductions in urine flow and sodium excretion, it is possible that the renal sympathetic nerves were maximally activated and exerting maximal antidiuretic and antinatriuretic effects under control conditions, and thus hemorrhage failed to elicit a further increase in efferent sympathetic nerve activity. In this regard, it should be recognized that the present experiments were performed in anesthetized surgically stressed rats, which have been shown to have an increased activity of the sympathetic nervous system compared with unanesthetized rats. Furthermore, the basal hematocrits indicate that the rats were hydropenic, which would further activate the sympathetic nervous system. Thus it is possible that the effects of hemorrhage to reduce urine flow and sodium excretion were masked by the already low basal levels of urine flow and sodium excretion resulting from the elevated level of activity of the sympathetic nervous system induced by anesthesia, surgical stress, and altered volume status. Regardless, the finding that basal levels of urine flow and sodium excretion in the dye-injected kidneys were equally as low as those in the control kidneys suggests that the dye-injected kidneys did not have an impaired ability to retain salt and water under conditions in which the level of activity of the sympathetic nervous system was presumably markedly increased. In essence, the present findings suggest that the renal nerves were still capable of eliciting salt and water retention by the dye-injected kidney. Because the patch-clamp studies of SCG and renal efferent sympathetic neurons displayed no differences in the biophysical properties (4) or the neuromodulation of Ca2+ currents between fast blue-labeled and unlabeled neurons, it is unlikely that the dye-labeling procedure produces significant damage to the renal innervation. The possibility remains, however, that renal nerve or kidney function may be transiently altered sometime during the 1-wk recovery period between the dye injection and the time of the experiments. Further studies are required to address this issue.
In an effort to evaluate whether the dye-labeling procedure compromised the ability of the renal nerves to decrease activity and therefore results in an inappropriate retention of salt and water, renal function was examined after a 2.5% body wt saline volume expansion. In the present study, volume expansion increased urine flow by 2.5- to 3-fold and sodium excretion by 8- to 9-fold in both the dye-injected and control kidneys, without influencing renal hemodynamic function. However, the absolute magnitude of the volume expansion-induced increment in urine flow was slightly but significantly smaller in the dye-injected kidneys, indicating that these kidneys exhibited an impaired ability to respond appropriately to acute volume expansion. Nevertheless, the finding that volume expansion elicited marked increases in both urine flow and sodium excretion in the dye-injected kidneys clearly indicates that the dye injection procedure does not substantively interfere with the renal response to volume expansion.
The present observation that the membrane capacitance and series
resistance values of labeled and unlabeled neurons with and without UV
exposure were not different suggests that it is unlikely that the
neuronal geometry or size was influenced by the dye label or UV
exposure during identification. Because
Ca2+ current amplitudes of SCG
neurons or PVG neurons were not affected by the presence of the dye
label and/or the UV exposure required to identify and position a neuron
for recording, it appears that the procedure has no deleterious effect
on neuronal function. A more rigorous test of the effects of the dye
label or the UV exposure was provided by comparing neuromodulation of
Ca2+ currents in labeled and
unlabeled neurons. Intact norepinephrine-induced neuromodulation of
Ca2+ currents requires functional
receptors and channels and preservation of the G protein signaling
pathway. The observation that the sensitivity (Kd) for
norepinephrine and maximal inhibition were not different between the
four groups strongly suggests that the norepinephrine receptors were
not affected by the presence of the dye label or UV exposure. Moreover,
because the percent facilitation and time constant of recovery of
inhibition recorded in 10 µM norepinephrine were similar between the
four groups, it seems unlikely that the dye or UV exposure compromised
G protein signaling in these neurons. We chose to examine
Ca2+ currents and their
neuromodulation because Ca2+
currents play a vital part in the neuronal control of renal function, by virtue of their role in transmitter release from sympathetic nerve
terminals. At the terminals, norepinephrine release can be inhibited by
modulation of the Ca2+ current via
2-adrenoceptor activation. In
addition, the effects of norepinephrine can be monitored as current
inhibition and by depolarization-induced facilitation, the latter being
a specific indicator of N-channel inhibition. Thus we expected
assessment of Ca2+ currents and
their modulation would be a sensitive indicator of neuronal function.
Although there were no differences detected in any of the
Ca2+ current parameters tested,
the possibility remains that other conductance systems could be
affected by this dye-labeling procedure that might alter neuronal
function. Further experiments would be required to address this issue.
Perspectives
It is generally recognized that the renal nerves play an important role in the regulation of renal function in normal and pathophysiological conditions. However, little information is available regarding the specific electrophysiological characteristics of the neurons. Whereas it has been assumed that the electrophysiological properties of the renal efferent sympathetic neurons are identical to those of other sympathetic neurons, there is growing recognition that considerable heterogeneity exists within the sympathetic nervous system. For example, receptor autoradiography has demonstrated that discrete neuronal populations within various sympathetic ganglia express binding sites for specific neuropeptides, suggesting a fine control of postganglionic neurons by neuropeptides released from pre- and postganglionic sympathetic neurons (16). At the electrophysiological level, different action potential discharge patterns of anatomically distinct neurons within a given ganglion have been observed (3). The discharge patterns of two populations of sympathetic neurons were correlated with their apparent function. Neurons that had a phasic firing pattern were vasoconstrictor, whereas neurons that had a tonic firing pattern were involved with visceral motility (3). The present study demonstrates that renal projection neurons can be selectively identified using a fluorescent dye-tracing technique that does not compromise renal function or Ca2+ current function or modulation in these neurons. This method therefore provides a tool to study the role of these neurons in the regulation of renal function in both normotensive conditions and pathophysiological states.| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. S. R. Ikeda, Guthrie Research Institute, for data acquisition software; Dr. K. D. Mitchell, Tulane University Medical School, for insightful discussion and advice on the manuscript; and Dr. C. Chen, Louisiana State University Medical College, who collected the data from the paravertebral ganglion neurons.
| |
FOOTNOTES |
|---|
This work was supported by National Heart, Lung, and Blood Institute Grant HL-48796.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: G. G. Schofield, Dept. of Physiology SL39, Tulane Univ. School of Medicine, New Orleans, LA 70112 (E-mail: solar{at}maihost.tcs.tulane.edu).
Received 13 October 1998; accepted in final form 21 June 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Arendshorst, W. J.,
and
C. W. Gottschalk.
Glomerular ultrafiltration dynamics: euvolemic and plasma volume-expanded rats.
Am. J. Physiol.
239 (Renal Fluid Electrolyte Physiol. 8):
F171-F186,
1980.
2.
Bean, B. P.
Neurotransmitter inhibition of neuronal calcium currents by changes in channel voltage dependence.
Nature
340:
153-156,
1989[Medline].
3.
Cassell, J. F.,
A. L. Clark,
and
E. M. McLachlan.
Characteristics of phasic and tonic sympathetic ganglion cells of the guinea pig.
J. Physiol. (Lond.)
372:
457-483,
1986
4.
Chen, C.,
and
G. G. Schofield.
Calcium currents of fast blue labeled superior cervical ganglion neurons.
J. Neurosci. Methods
45:
63-69,
1992[Medline].
5.
DiBona, G. F.
Sympathetic nervous system influences on the kidney. Role in hypertension.
Am. J. Hypertens.
2:
1195-1245,
1989.
6.
DiBona, G. F.,
and
U. C. Kopp.
Neural control of renal function.
Physiol. Rev.
77:
76-197,
1997.
7.
Ehrlich, I.,
and
K. S. Elmslie.
Neurotransmitters acting via different G proteins inhibit N-type calcium current by an identical mechanism in rat sympathetic neurons.
J. Neurophysiol.
74:
2251-2257,
1995
8.
Elmslie, K. S.,
W. Zhou,
and
S. W. Jones.
LHRH and GTP-
-S modify calcium current activation in bullfrog sympathetic neurons.
Neuron
5:
75-80,
1990[Medline].
9.
Fuhr, J.,
J. Kazmarczyk,
and
C. D. Kruttgen.
Eine einfache colorimetrische Methode zur Inulin-Bestimmung fur Nieren-clearance Untersuchungen bei Stoffwechsel
Gesunden and Diabetikein.
Klin. Wochenschr.
33:
729-730,
1955[Medline].
10.
Golard, A.,
and
S. A. Siegelbaum.
Kinetic basis for the voltage-dependent inhibition of N-type calcium current by somatostatin and norepinephrine in chick sympathetic neurons.
J. Neurosci.
13:
3884-3894,
1993[Abstract].
11.
Grassi, F.,
and
H. D. Lux.
Voltage-dependent GABA-induced modulation of calcium currents in chick sensory neurons.
Neurosci. Lett.
105:
113-119,
1989[Medline].
12.
Guyton, A. C.
Abnormal renal function and autoregulation in essential hypertension.
Hypertension
18, Suppl. III:
III-49-III-53,
1991.
13.
Hamill, O. P.,
A. Marty,
E. Neher,
B. Sakmann,
and
F. J. Sigworth.
Improved patch-clamp techniques for high-resolution recording from cells and cell-free membrane patches.
Pflügers Arch.
391:
85-100,
1981[Medline].
14.
Janssen, B. J. A.,
and
J. F. M. Smits.
Renal nerves in hypertension.
Miner. Electrolyte Metab.
15:
74-82,
1989[Medline].
15.
Luebke, J. I.,
F. F. Weight,
and
L. G. Aguayo.
Labeling and recording from dissociated target-specific rat superior cervical ganglion neurons.
Neurosci. Lett.
135:
210-214,
1992[Medline].
16.
Mantyh, P. W.,
M. D. Catton,
C. J. Allen,
M. E. Labenski,
J. E. Maggio,
and
S. R. Vigna.
Receptor binding sites for cholecystokinin, galanin, somatostatin, substance and vasoactive intestinal polypeptide in sympathetic ganglia.
Neuroscience
46:
739-754,
1992[Medline].
17.
Mendelowitz, D.,
and
D. L. Kunze.
Identification and dissociation of cardiovascular neurons from the medulla for patch clamp analysis.
Neurosci. Lett.
132:
217-221,
1991[Medline].
18.
Purves, D.
Functional and structural changes in mammalian sympathetic neurones following interruption of their axons.
J. Physiol. (Lond.)
252:
429-463,
1975
19.
Sanchez-Vives, M. V.,
and
R. Gallego.
Effects of axotomy or target atrophy on membrane properties of rat sympathetic ganglion cells.
J. Physiol. (Lond.)
471:
801-815,
1993
20.
Sanchez-Vives, M. V.,
M. Valdeolmillos,
S. Martinez,
and
R. Gallego.
Axotomy-induced changes in Ca2+ homeostasis in rat sympathetic ganglion cells.
Eur. J. Neurosci.
6:
9-17,
1994[Medline].
21.
Schofield, G. G.
Norepinephrine inhibits a calcium current in rat sympathetic neurons via a G-protein.
Eur. J. Pharmacol. Mol. Pharmacol. Sect.
207:
195-207,
1991[Medline].
22.
Schofield, G. G.,
and
S. R. Ikeda.
Sodium and calcium currents of acutely isolated adult rat superior cervical ganglion neurons.
Pflügers Arch.
411:
481-490,
1988[Medline].
23.
Sripairojthikoon, W.,
and
J. M. Wyss.
Cells of origin of the sympathetic renal innervation in the rat.
Am. J. Physiol.
252 (Renal Fluid Electrolyte Physiol. 21):
F957-F963,
1987
24.
Thoren, P.
Efferent renal nerve traffic in the spontaneously hypertensive rat.
Clin. Exp. Hypertens. Suppl.
1:
135-150,
1987.
25.
Vari, R. C.,
S. D. Adkins,
and
W. K. Samson.
Renal effects of adrenomedullin in the rat.
Proc. Soc. Exp. Biol. Med.
211:
178-183,
1996[Abstract].
26.
Waugh, W. H.,
and
P. T. Beal.
Simplified measurement of p-aminohippurate and other arylamines in plasma and urine.
Kidney Int.
5:
429-436,
1974[Medline].
27.
Wyss, M. J.,
and
W. Sripairojthikoon.
Tracing neuronal connections in the periphery: renal nerves.
Methods Neurosci.
3:
275-290,
1990.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |